HTA32 Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1817
https://www.valueinhealthjournal.com/article/S1098-3015(25)04374-8/fulltext
Title :
HTA32 Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04374-8&doi=10.1016/j.jval.2025.09.1817
First page :
Section Title :
Open access? :
No
Section Order :
11352